Position in PFE
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$882,314
-$155,185 QoQ
Shares Held
36,641
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#1,400
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 62%
Shared 38%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PEOPLES FINANCIAL SERVICES CORP. holds $30,501,464 across 11 Drug Manufacturers - General names. PFE ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
11,244 | $13,486,391 | |
| 2 | JNJ |
Johnson & Johnson
|
19,251 | $4,889,175 | |
| 3 | ABBV |
AbbVie Inc.
|
18,482 | $4,650,810 | |
| 4 | MRK |
Merck & Co., Inc.
|
22,170 | $2,848,845 | |
| 5 | AMGN |
Amgen Inc
|
4,453 | $1,612,520 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
26,066 | $1,501,922 | |
| 7 | PFE |
Pfizer Inc
This page
|
36,641 | $882,314 | |
| 8 | NVS |
Novartis AG
|
1,703 | $266,893 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $882,314 | 36,641 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $1,037,499 | 36,948 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $932,380 | 37,445 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,024,168 | 40,195 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $978,423 | 40,364 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,080,294 | 42,632 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,160,209 | 43,732 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $1,333,670 | 46,084 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,605,436 | 57,378 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $2,102,423 | 75,763 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $2,400,250 | 83,371 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $2,838,157 | 85,564 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $3,339,236 | 91,037 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $3,777,753 | 92,592 | Shares | Sole | 2023-04-13 | |
| 2022-12-31 | $4,798,728 | 93,652 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $4,089,415 | 93,451 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $4,941,474 | 94,249 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $5,013,820 | 96,848 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $6,006,152 | 101,713 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $4,374,675 | 101,713 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $4,006,772 | 102,318 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $3,680,532 | 101,588 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $3,779,024 | 102,663 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $3,722,953 | 101,443 | Shares | Sole | 2020-10-07 | |
| 2020-06-30 | $3,299,236 | 100,894 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $3,286,973 | 100,704 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||